Antiviral Therapy · 2005 · 29 citations · 31 references
Life SciencesCell BiologyMolecular BiologyCellular MetabolismGene ExpressionMitochondrial BiologyAdipose TissueAntiretroviral TherapyMitochondrial BiochemistryMitochondrial DysfunctionMitochondrial Gene ExpressionMitochondrial PhysiologyHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyMitochondrial Rna Processing DefectsMitochondrial TranscriptomeNucleoside Reverse Transcriptase InhibitorsTranscripts
Background Damage to mitochondria (mt) is a major side effect of highly active antiretroviral therapy (HAART) that includes a nucleoside reverse transcriptase inhibitor (NRTI). Such damage is associated with the onset of lipodystrophy in HAART-treated HIV+ patients. To further investigate mt changes during this syndrome, we analysed the expression of mtRNA in adipocytes from lipodystrophic HIV+ patients taking NRTI-containing HAART and compared it with similar cells from healthy individuals. Materials and methods Total RNA was extracted from adipocytes collected from different anatomical locations of 11 HIV+ lipodystrophic patients and seven healthy control individuals. RNA was reverse transcribed and Taqman-based real-time PCR was used to quantify three different mt transcripts (ND1, CYTB and ND6 gene products). mtRNA content was normalized versus the housekeeping transcript L13. Results ND1, CYTB and ND6 expression was significantly reduced in HIV+ lipodystrophic patients. HIV+ men and women did not differ in a statistically significant way regarding the levels of ND1 and ND6, whereas the opposite occurred for CYTB. Conclusions Lipodystrophy following treatment with NRTI-containing HAART is associated with a decrease in adipose tissue mtRNAs.
31
Sequence and organization of the human mitochondrial genome
Stephen K. Anderson, Alan T. Bankier, B. G. Barrell et al. · Nature · 1981 · 9.7K citations
Andrew Carr, J. Philip Miller, Matthew Law et al. · AIDS · 2000 · 641 citations